MedPath

Safety and efficacy of skin care formulatio

Not Applicable
Registration Number
CTRI/2022/01/039134
Lead Sponsor
Kama Ayurveda Pvt Ltd
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Having moderate to severe hair fall.

Having Moderate to severe dandruff where 0 is None, 1 is Slight, 2 is Mild, 3 is Moderate, 4

is Severe

Suffering with hair thinning on subject assessment basis.

For female: Having at least shoulder length hair.

Having washed their hair with provided neutral shampoo, 48 hours before the first day of the

study with the provided nuetral shampoo.

Having untangled their hair at home, 3 hours prior coming to the site for observations, the first

day of the study.

Exclusion Criteria

Small, red bumps on the scalp, neck, and shoulders (bumps may become crusty and ooze)

Subject having applied a product with an anti-hair fall claim (due to breakage)or anti dandruff claim in the 2 weeks preceding the start of the study

Having surgery history on the scalp (micro transplants â?¦)

In the previous 6 months

- Having undergone the Minoxidil treatments

- Antiandrogen medicine (cyproterone acetate, spironolactone, flutamide)

- Having undergone one of the following treatments known to : induce hair loss : retinoids, anti coagulants, anti-convulsive drugs, chemotherapy, beta-blocking agents, non steroidal anti inflammatory drugs, corticoids â?¦

- Having modified her hormonal contraception

In the previous 3 months

- Having undergone a local or general anti hair loss treatment (Biotine, dexpanthenol, sulphur amino-acid, B6 vitamin, zinc â?¦)

- Having taken a food supplement with an anti hair loss claim

- Having taken an iron based treatment

In the previous 15 days

- Having applied a product with an anti hair loss claim (due to breakage) or anti dandruff claim

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
efficacy of hair care formulation in <br/ ><br>terms of reduction in Hair Fall and Anti-dandruff effectTimepoint: T0, T14 days and T28 days
Secondary Outcome Measures
NameTimeMethod
SafetyTimepoint: T0, T14 days and T28 days
© Copyright 2025. All Rights Reserved by MedPath